Last 1.61 INR
Change Today +0.07 / 4.55%
Volume 1.6K
GRD On Other Exchanges
Symbol
Exchange
Mumbai
As of 5:00 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

hindustan bio sciences ltd (GRD) Snapshot

Open
1.61
Previous Close
1.54
Day High
1.61
Day Low
1.61
52 Week High
09/17/14 - 2.15
52 Week Low
03/11/14 - 0.72
Market Cap
16.5M
Average Volume 10 Days
1.9K
EPS TTM
-0.97
Shares Outstanding
10.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HINDUSTAN BIO SCIENCES LTD (GRD)

Related News

No related news articles were found.

hindustan bio sciences ltd (GRD) Related Businessweek News

No Related Businessweek News Found

hindustan bio sciences ltd (GRD) Details

Hindustan Bio Sciences Limited imports and markets recombinant human erythropoietin under the brand names of EPOVIN, EPOSINO, and TRANSFER & NEPHRODIL in India. The company was incorporated in 1991 and is based in Hyderabad, India.

Founded in 1991

hindustan bio sciences ltd (GRD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hindustan bio sciences ltd (GRD) Key Developments

Hindustan Bio Sciences Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Hindustan Bio Sciences Ltd. reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the second quarter, the company reported income from operations of INR 3.498 million compared to INR 6.429 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 1.592 million compared to INR 2.191 million a year ago. Net loss from ordinary activates after tax was INR 1.692 million compared to INR 2.268 million a year ago. Net loss for the period was INR 1.692 million or INR 0.17 per share, compared to INR 2.268 million or INR 0.22 per share, a year ago. For the six months, the company reported income from operations of INR 3.707 million compared to INR 9.967 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 10.927 million compared to INR 5.216 million a year ago. Net loss from ordinary activates after tax was INR 11.096 million compared to INR 5.339 million a year ago. Net loss for the period was INR 11.096 million or INR 1.08 per share, compared to INR 5.339 million or INR 0.52 per share, a year ago.

Hindustan Bio Sciences Ltd., Board Meeting, Oct 31, 2014

Hindustan Bio Sciences Ltd., Board Meeting, Oct 31, 2014. Agenda: To approve quarterly results.

Hindustan Bio Sciences Ltd., Annual General Meeting, Sep 30, 2014

Hindustan Bio Sciences Ltd., Annual General Meeting, Sep 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GRD:IN 1.61 INR +0.07

GRD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GRD.
View Industry Companies
 

Industry Analysis

GRD

Industry Average

Valuation GRD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.0x
Price/Book 0.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HINDUSTAN BIO SCIENCES LTD, please visit www.hindustanbiosciences.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.